Trial Profile
Continuous administration trial of OTS11101.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs OCV 101 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Expanded access
- 12 Jun 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 17 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 15 Dec 2009 New trial record